Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating host cellular immune responses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples